Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Establishes through the department of health a drug checking services program to allow individuals to bring drugs or controlled substances and have them tested for contaminants, toxic substances, or hazardous compounds; requires the department to establish public health surveillance of the unregulated drug supply; provides exemptions for participants in the drug checking program from certain controlled substance offenses.
Includes the recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians and/or other similar nationally or internationally recognized scientific organizations in the establishment of immunization administration regulations.
This bill creates the "Lab Services Accessibility Act," which modifies New York's public health law to expand exemptions for clinical laboratories providing specific public health services. It directly affects clinical laboratories and health service providers operating under public health programs, such as pregnancy testing, sexually transmitted infection screening, pandemic response, and care for underserved populations. Key provisions (Section 3) add new payment exemptions, allowing services for these programs to be covered without triggering certain regulatory requirements - specifically, by entities like hospitals, insurers, or public health initiatives. The law aims to streamline access to essential lab services by clarifying payment pathways for priority health needs.
Requires the administration of certain vaccines for children in accordance with regulations issued by the commissioner, utilizing generally accepted medical standards and based on recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the Advisory Committee on Immunization Practices, and/or other similar nationally or internationally recognized scientific organizations; removes certain requirements for vaccines to be administered under federal guidance.
This bill (S 707) requires managed long term care plans in New York to include specific data in annual reports to the state Department of Health, replacing previous biannual reporting. It mandates detailed metrics on service utilization (like hours of personal care), expenditures (broken down by service type), complaint resolution rates, timely access to care, and rebalancing efforts shifting care from nursing homes to home-based settings. These reports must be published annually on the Department’s website in an interactive format for public comparison, covering statewide and regional data. The changes directly affect managed care plans (which provide long-term care services), the Department of Health (which collects and publishes the data), and enrollees (whose care quality and access are measured).
Bill S 3689 amends the real property actions and proceedings law to protect tenants using medical marihuana. It prohibits landlords from evicting a tenant from a residential unit solely because of their certified medical use of medical marihuana. The bill establishes this as a defense for tenants in eviction proceedings. However, it also clarifies that landlords retain their legal rights to recover possession for any other lawful grounds not related to medical marihuana use.
This bill requires most health insurance plans sold in the state to cover pharmacist-provided contraceptive services, such as counseling, prescribing, or dispensing. It directly affects health insurers and patients seeking contraceptive care through pharmacies. The key provision mandates that insurance policies include these specific services without extra costs to the patient. The bill passed the Senate in January 2026 and is now under review by the Assembly's Insurance committee.
Requires the administration of certain vaccines for children in accordance with regulations issued by the commissioner, utilizing generally accepted medical standards and based on recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the Advisory Committee on Immunization Practices, or other similar nationally or internationally recognized scientific organizations.
Relates to the establishment of regulations for administering immunizations taking into consideration the recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the advisory committee on immunization practices, any interstate body established for purposes of reviewing and making recommendations regarding immunization coverage and access, or other similar nationally or internationally recognized scientific organizations.